Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California.

Bojorquez I, Barnes RF, Flood J, López-Gatell H, Garfein RS, Bäcker CE, Alpuche C, Vinetz JM, Catanzaro A, Kato-Maeda M, Rodwell TC.

Am J Public Health. 2013 Jul;103(7):1301-5. doi: 10.2105/AJPH.2012.301039. Epub 2013 May 16.

2.

Tuberculosis along the United States-Mexico border, 1993-2001.

Schneider E, Laserson KF, Wells CD, Moore M.

Rev Panam Salud Publica. 2004 Jul;16(1):23-34.

PMID:
15333263
3.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

4.

Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis.

Bojorquez-Chapela I, Bäcker CE, Orejel I, López A, Díaz-Quiñonez A, Hernández-Serrato MI, Balandrano S, Romero M, Téllez-Rojo Solís MM, Castellanos M, Alpuche C, Hernández-Ávila M, López-Gatell H.

Int J Tuberc Lung Dis. 2013 Apr;17(4):514-9. doi: 10.5588/ijtld.12.0167.

PMID:
23485385
5.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
6.

Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective.

Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, Laniado-Laborin R, Estrada-Guzman J, Rodwell TC.

Int J Tuberc Lung Dis. 2013 Jul;17(7):954-60. doi: 10.5588/ijtld.12.0480.

7.

Treatment of multidrug-resistant tuberculosis in a high-prevalence region through a binational consortium.

Laniado-Laborín R, Estrada-Guzman J, Perez H, Batiz-Armenta F, Alcantar-Schramm JM.

Int J Tuberc Lung Dis. 2012 May;16(5):610-1. doi: 10.5588/ijtld.11.0544. Epub 2012 Mar 7.

PMID:
22410353
8.

Multidrug resistance among persons with tuberculosis in California, 1994-2003.

Granich RM, Oh P, Lewis B, Porco TC, Flood J.

JAMA. 2005 Jun 8;293(22):2732-9. Erratum in: JAMA. 2005 Jul 6;294(1):44.

PMID:
15941802
9.

Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.

Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D.

Euro Surveill. 2013 Oct 17;18(42). pii: 20609.

10.

Risk factors for multidrug-resistant tuberculosis in Hong Kong.

Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC.

Int J Tuberc Lung Dis. 2008 Sep;12(9):1065-70.

PMID:
18713506
11.

Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.

Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y, Sun H, Yan X, Li F, Li H, Fang H, Ning N, Cui Y, Han L.

Thorax. 2012 Jul;67(7):632-8. doi: 10.1136/thoraxjnl-2011-200018. Epub 2012 Mar 8.

PMID:
22403070
12.

Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.

Melzer M, Gupta N, Petersen I, Cook S, Hall B.

Int J Infect Dis. 2010 Aug;14(8):e717-22. doi: 10.1016/j.ijid.2010.02.2247. Epub 2010 Jun 12.

13.
14.

Characteristics of foreign-born Hispanic patients with tuberculosis--eight U.S. counties bordering Mexico, 1995.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1996 Nov 29;45(47):1032-6.

15.

Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.

Liu Z, Shilkret KL, Finelli L.

Int J Epidemiol. 1998 Feb;27(1):121-6.

16.

Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997.

Granich RM, Balandrano S, Santaella AJ, Binkin NJ, Castro KG, Marquez-Fiol A, Anzaldo G, Zarate M, Jaimes ML, Velazquez-Monroy O, Salazar L, Alvarez-Lucas C, Kuri P, Flisser A, Santos-Preciado J, Ruiz-Matus C, Tapia-Conyer R, Tappero JW.

Arch Intern Med. 2000 Mar 13;160(5):639-44.

PMID:
10724049
17.

Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z.

Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.

18.

Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.

Faustini A, Hall AJ, Perucci CA.

Thorax. 2006 Feb;61(2):158-63. Epub 2005 Oct 27. Review.

19.

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, van Gemert W, Hoffner S, Rusovich V, Zignol M.

Eur Respir J. 2012 Jun;39(6):1425-31. doi: 10.1183/09031936.00145411. Epub 2011 Oct 17.

20.

Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.

Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.

Int J Tuberc Lung Dis. 2006 Aug;10(8):844-50.

PMID:
16898367
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk